Inflammation Clinical Trial
Official title:
Effect of Extractions and Straumann Dental Implants on Glycemic Control and Inflammatory Markers in Patients With Diabetes: A Pilot Study
Verified date | November 2018 |
Source | University of Michigan |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Gum disease and type 2 diabetes are common chronic diseases that affect each other. Diabetes
is increasing, especially in Pakistan. People with diabetes have a greater risk for gum
disease. Also, it is thought that that gum disease, a chronic infection, can be a source of
systemic inflammation and may contribute to poorer diabetes control.
The aims of this project are to study:
1. Changes in sugar control in people with type 2 diabetes and severe gum disease after
having all teeth removed and replaced with Straumann dental implants and full dentures
2. Changes in certain inflammation markers seen with insulin resistance and other diseases
and conditions more common in people with diabetes
3. Retention of dental implants in people with type 2 diabetes.
Part I (up to 12 months after implant placement):
The study will recruit 30 patients with type 2 diabetes and severe gum disease from Dr. Amin
Rahman's private practices in Pakistan. Their long-term sugar (HbA1c) must be 7.5% or more
and the inflammatory marker, C-reactive protein (hsCRP) 1mg/dL or more. Consenting
participants will first have an oral examination. Eligible patients will have impressions of
the jaws and the color of their teeth and gums recorded. At the next visit, all teeth will be
extracted and dentures provided. One week later, there will be a check-up visit. Three months
after the teeth were removed, Straumann dental implants will be placed in the jaws. After one
week, the patient will be checked again. After three months, the dentures will be adjusted to
fit the implants. Follow-up visits will occur every three months until one year after the
implants were placed to check the health of the patients as well as their implants, the gums
around them, and the dentures. Blood samples will be taken at each follow-up visit.
Part II (from 12 months to 11 years after implant placement):
Follow-up visits will occur every six months for the next ten years, to check the health of
the patients as well as their implants, the gums around them, and the dentures. The follow-up
visit will be identical to those done in Part I, including blood samples.
Status | Completed |
Enrollment | 30 |
Est. completion date | August 28, 2015 |
Est. primary completion date | August 28, 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion criteria: - type 2 diabetes of at least 6 months duration and uncontrolled (HbA1c at least 7.5%) - all teeth in dentition in need of extraction due to periodontal (gum) disease (end-stage or terminal periodontitis) - able to return for examination every three months for the first year after implant placement, then every 6 months for five years after implant placement - willing to have blood drawn at each follow-up visit Exclusion criteria: - = 6 natural teeth - inflammatory conditions/diseases other than type 2 diabetes |
Country | Name | City | State |
---|---|---|---|
Pakistan | Rahman & Rahman Dental Surgeons | Lahore | Punjab |
Lead Sponsor | Collaborator |
---|---|
University of Michigan | Rahman & Rahman Dental Surgeons, Lahore, Pakistan |
Pakistan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Retention of implants | Implants sometimes fail if placed in individuals with uncontrolled diabetes, recent infection/inflammation, and cigarette smoking habits. The intent is to evaluate retention of implants in such patients. | 6 years | |
Primary | Glycosylated hemoglobin (HbA1a) | Level measured every 3 months during the first year after implant placement; then every 6 months the following 5 years, for a total of 6 years. | Every 3 months/6 months | |
Secondary | high-sensitivity C-reactive protein (hsCRP) | Level measured every 3 months during the first year after implant placement; then every 6 months the following 5 years, for a total of 6 years. | Every 3 months/6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03995979 -
Inflammation and Protein Restriction
|
N/A | |
Completed |
NCT03255187 -
Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT03577223 -
Egg Effects on the Immunomodulatory Properties of HDL
|
N/A | |
Completed |
NCT04383561 -
Relationship Between LRG and Periodontal Disease
|
N/A | |
Active, not recruiting |
NCT03622632 -
Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
|
||
Completed |
NCT06216015 -
Exercise Training and Kidney Transplantation
|
N/A | |
Completed |
NCT04856748 -
Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
|
||
Completed |
NCT05529693 -
Efficacy of a Probiotic Strain on Level of Markers of Inflammation in an Elderly Population
|
N/A | |
Recruiting |
NCT05670301 -
Flemish Joint Effort for Biomarker pRofiling in Inflammatory Systemic Diseases
|
N/A | |
Recruiting |
NCT05415397 -
Treating Immuno-metabolic Depression With Anti-inflammatory Drugs
|
Phase 3 | |
Recruiting |
NCT05775731 -
Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
|
||
Recruiting |
NCT04543877 -
WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study
|
Early Phase 1 | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Completed |
NCT03429920 -
Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors
|
N/A | |
Completed |
NCT06065241 -
Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory Biomarkers and Epigenetic Changes in Healthy, Older Individuals.
|
N/A | |
Completed |
NCT05864352 -
The Role of Dietary Titanium Dioxide on the Human Gut Microbiome and Health
|
||
Completed |
NCT03318731 -
Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males
|
N/A | |
Not yet recruiting |
NCT06134076 -
Comparing Effects of Fermented and Unfermented Pulses and Gut Microbiota
|
N/A | |
Not yet recruiting |
NCT06422494 -
The Role of the Adrenergic System in Hypoglycaemia Induced Inflammatory Response in People With Type 1 Diabetes and People Without Type 1 Diabetes-RAID-II
|
N/A |